Drug executives come to DC as Republicans grapple with how to stop runaway prices
WASHINGTON - In a much-anticipated piece of political theater, seven leading pharmaceutical executives appeared before a powerful Senate committee Tuesday for a grilling from lawmakers who pledged a historic bipartisan effort to rein in skyrocketing prescription drug prices.
But even as drug prices have emerged as one of the few areas of common concern for President Donald Trump and congressional Democrats, the drugmakers made no firm commitments to lower prices, and lawmakers - particularly Republicans - are far from settling on a strategy to encourage or even force companies to lower their prices.
And although the Trump administration has taken a number
